NCT03509857View on ClinicalTrials.gov

Vibration Analgesia in Propofol Infusion During Anesthesia Induction

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Pain, Acute
Interventions
DEVICE

BUZZY(tm)

"Risks associated with the BUZZY(tm) device The intervention group will receive vibration only, with application of the BUZZY device just proximal to the intravenous infusion site immediately before and during propofol infusion.~There are no known risks for the use of the BUZZY(tm) device, which is registered as an FDA class III device (therapeutic massager)."

OTHER

No Intervention

No intervention

Trial Locations (1)

10461

Montefiore Hutchinson Campus, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT03509857 - Vibration Analgesia in Propofol Infusion During Anesthesia Induction | Biotech Hunter | Biotech Hunter